Navigation Links
ADHD Medications Don't Pose Cancer Risk
Date:11/21/2008

Study found 2 popular drugs do not cause genetic damage that can lead to disease

FRIDAY, Nov. 21 (HealthDay News) -- Two popular medications for treating attention-deficit hyperactivity disorder (ADHD) do not cause genetic damage linked to an increased risk for developing cancer, a new study says.

The study, done by researchers at Duke University Medical Center and the National Institutes of Health, counters a previous one that reported biomarkers associated with an increased cancer risk were present in the blood of children taking the ADHD drug methylphenidate.

"The new findings should help alleviate some of the concerns that were raised by the previous study," study co-author Scott Kollins, director of Duke's ADHD program, said in a university news release. "However, we need to continue to study the long-term effects of these medications and expand our analyses to include older patient populations."

The new study, which looked at methylphenidate (Ritalin LA and Concerta) and amphetamine (Adderall and Adderall XR), used a larger study sample and conditions that apply to a wider cross-section of children with ADHD than the initial study did, he said.

"We looked at three common markers associated with damaged chromosomes and did not find increased genetic abnormalities in children taking either medication, regardless of a variety of factors, such as age, sex, body weight, height, race or ADHD subtype," Kollins said.

About 2 million children have ADHD, a condition commonly characterized by inattention, hyperactivity and impulsivity. Methylphenidates and amphetamines have been used to treat the condition for decades, with millions of prescriptions written for them in the United States every year.

The study was published in the November online issue of the Journal of the American Academy of Child & Adolescent Psychiatry.

More information

The U.S. National Institute of Mental Health has more about ADHD.



-- Kevin McKeever



SOURCE: Duke University Medical Center, news release, Nov. 19, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New study: A Common Class of GI Medications Reduce Protection Against Heart Attack in Patients Taking Widely Prescribed Cardiovascular Drug
2. Naturally Safe Cold Remedy Challenges Effectiveness of Over-The-Counter Cold Medications
3. Triglyceride Levels Continue to Rise in the United States Despite Increased Use of Cholesterol-Lowering Medications
4. New Google Health Application Helps Users Find Patient Assistance Programs for Medications Using PatientAssistance.com
5. Anti-inflammatory medications may become a treatment for schizophrenia
6. VIDEO from Medialink and Philips: Microbubbles Developed to Administer Medications That Fight Cancer and Reduce Side Effects
7. Researchers Examine Safety of Internet Prescriber Service Providing Erectile Dysfunction Medications
8. Researchers examine safety of Internet prescriber service providing erectile dysfunction medications
9. Allergic-like reactions to iodinated contrast material treated safely with commonly used medications
10. Study Measures Real-World Comparative Effectiveness of Asthma Controller Medications
11. National Headache Foundation Offers Statement, Experts on Appropriate Use of Medications for Migraine Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
ADHD Medications Don't Pose Cancer Risk
(Date:3/23/2017)... ... 2017 , ... The Boulevard is honored to host Shriners and Masons Children’s ... located in the Main West Entrance of The Boulevard (in front of JCPenney). ... necessary and each child with a parent or guardian will be photographed for free ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... News Advisory/Interview ... Choice has helped score a major victory in Europe for public health and the ... , Based on rigorous scientific research and the overwhelming support of European citizens, ...
(Date:3/23/2017)... ... March 23, 2017 , ... “Wounded Woman Be Ye Healed-Passing On A Legacy”: ... A Legacy” is the creation of published author, Desiree M Webb, a registered nurse, ... She has been happily married to her husband, Paul, for over twenty-nine years. ...
(Date:3/23/2017)... ... March 23, 2017 , ... Ogden ... innovative patient - centric payment system, to expand its focus on patient care ... patient financial experience. , “At Ogden Clinic, we are working to become ...
(Date:3/23/2017)... ... ... Trainer”: an electrifying and suspenseful gunslinger novel with a twist. “The Trainer” is ... an enthusiasm for action and adventure stories. , Published by Christian Faith ... at the thirty-three notches that lined the edges of the wooden grip plates of ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... Global Colposcope Market by Manufacturers, Countries, Type and Application, ... especially in North America , Europe ... America , Middle East and ... manufacturers, regions, type and application. ... Browse 190 Tables and Figures, 19 Major Company Profiles, ...
(Date:3/23/2017)... , Mar 23, 2017 NeuroVive ... company, today announced that the English version of the Annual ... www.neurovive.com .  ... About NeuroVive NeuroVive Pharmaceutical AB is ... the discovery and development of medicines that preserve mitochondrial integrity ...
(Date:3/22/2017)... March 22, 2017  DarioHealth Corp. (NASDAQ: DRIO), ... health and big data solutions, today reported financial ... month period ended December 31, 2016. ... $2.8 million, increased 241% compared to the full ... growth throughout the entire year  ...
Breaking Medicine Technology: